| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -1.4 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.08 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.39 | 0.05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-05 |